πŸ‡ΊπŸ‡Έ FDA
Patent

US 11793815

Oxindoles and methods of use thereof

granted A61KA61K31/404A61K31/4245

Quick answer

US patent 11793815 (Oxindoles and methods of use thereof) held by Aligos Therapeutics, Inc. expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aligos Therapeutics, Inc.
Grant date
Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/404, A61K31/4245, A61K31/437, A61K31/451